MC-Gly-Gly-D-Phe Catalog number: BADC-01893

MC-Gly-Gly-D-Phe, a synthetic peptide derivative, is widely used in the design and synthesis of targeted drug delivery systems, particularly in the development of antibody-drug conjugates (ADCs). The molecule’s structure incorporates a maleimide (MC) functional group, enabling selective conjugation with thiol groups on antibodies, forming stable thioether linkages. This feature ensures precise attachment of cytotoxic payloads to antibodies, enhancing the therapeutic index and reducing systemic toxicity in cancer treatments.

The Gly-Gly-D-Phe sequence in MC-Gly-Gly-D-Phe serves as a cleavable linker in drug delivery applications. This peptide sequence is highly sensitive to enzymatic cleavage in the tumor microenvironment, where proteases such as cathepsins are overexpressed. Upon cleavage, the cytotoxic payload is released specifically at the target site, minimizing off-target effects and maximizing therapeutic efficacy. This selective activation mechanism makes MC-Gly-Gly-D-Phe a critical component in targeted therapies for oncology.

MC-Gly-Gly-D-Phe is also employed in the development of peptide-based prodrugs. The compound's cleavable linker properties allow for the design of prodrugs that remain inactive during systemic circulation and are activated only in the presence of specific enzymes. This controlled activation reduces side effects and enhances the pharmacokinetic profile of the therapeutic agents, making it a valuable tool in precision medicine.

In addition to drug delivery, MC-Gly-Gly-D-Phe is utilized in biochemical research to study enzymatic activity and protease specificity. By incorporating this peptide sequence into fluorogenic or chromogenic substrates, researchers can monitor protease activity in real-time. This application is vital in understanding disease mechanisms and developing diagnostic assays for conditions characterized by aberrant protease activity, such as cancer and inflammatory diseases.